BioPharma Credit PLC (OTCMKTS:BOPCF) Sees Large Increase in Short Interest

BioPharma Credit PLC (OTCMKTS:BOPCF) was the target of a significant increase in short interest during the month of March. As of March 13th, there was short interest totaling 59,027 shares, an increase of 47.4% from the February 26th total of 40,046 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ∞ days.

BioPharma Credit Stock Performance

BOPCF stock remained flat at $0.95 on Friday. The business’s 50 day moving average price is $0.88 and its two-hundred day moving average price is $0.89. BioPharma Credit has a twelve month low of $0.78 and a twelve month high of $1.00.

BioPharma Credit Company Profile

BioPharma Credit (OTCMKTS: BOPCF) is a closed-end investment company that specializes in providing debt financing solutions to the global life sciences sector. The firm offers a range of credit products—including senior secured loans, convertible loans and royalty monetization structures—designed to meet the capital needs of biotechnology and pharmaceutical companies across pre-clinical, clinical and commercial stages. By focusing on secured and structured credit, BioPharma Credit seeks to deliver consistent income while managing risk through collateralized arrangements and diversified portfolios.

Since its inception in 2016, the company has built a track record of partnering with innovative drug developers and medical technology firms.